Related Experiment Video
Updated: Dec 12, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Acute transverse myelitis in COVID-19 infection
Chian Chiang Nicholas Chow1, John Magnussen2, Jerome Ip2,3
1Emergency Department, Hornsby Ku-ring-gai Hospital, Sydney, New South Wales, Australia chow.nicholas@gmail.com.
This case study details a COVID-19 patient who developed acute transverse myelitis, a serious spinal cord inflammation. Prompt treatment with methylprednisone led to significant neurological recovery, highlighting COVID-19
Area of Science:
- Neurology
- Infectious Diseases
- Immunology
Background:
- COVID-19 is a global pandemic with diverse clinical manifestations.
- Neurological complications of COVID-19 are increasingly reported.
- Acute transverse myelitis is a rare but severe neurological condition.
More Related Videos
05:44Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
09:29Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Myocarditis I: Introduction